Sen. Kohl Joins Ranks Of DTC Legislation Sponsors
This article was originally published in The Pink Sheet Daily
Executive Summary
The Wisconsin Democrat's forthcoming bill would follow the "FDA Safety Act" and the "Pharmaceutical Advertising & Prudent Purchasing Act," both currently pending.
You may also be interested in...
FDA To Convene Two-Day Meeting On DTC Advertising
Agency requests public comment for Nov. 1-Nov. 2 meeting on risk/benefit information dissemination, presentation of brief summary for drugs, devices, vaccines and blood products.
Sen. Frist's Diagnosis On DTC: GAO Report, Two-Year Moratorium For New Drugs
Majority Leader Frist requests Government Accountability Office examine FDA's oversight of direct-to-consumer ads and their impact on drug usage and costs. The senator also requests drug companies voluntarily restrict DTC ads during the first two years a product is on the market.
DTC Advertising Bill Would Mandate Deeper Rx Discounts For Medicaid
Legislation introduced by Sens. Wyden (D-Ore.) and Sununu (R-N.H.) is aimed at reducing federal program costs for the most commonly advertised drugs. The Pharmaceutical Advertising & Prudent Purchasing Act also would require a study on ways to reduce Medicare costs for drugs promoted through DTC campaigns.